| 0.8 |
2.4 |
GO:0016344 |
meiotic chromosome movement towards spindle pole(GO:0016344) |
| 0.7 |
4.3 |
GO:0021797 |
forebrain anterior/posterior pattern specification(GO:0021797) |
| 0.7 |
2.6 |
GO:0007056 |
spindle assembly involved in female meiosis(GO:0007056) |
| 0.5 |
1.6 |
GO:0034310 |
primary alcohol catabolic process(GO:0034310) |
| 0.5 |
2.1 |
GO:0010796 |
regulation of multivesicular body size(GO:0010796) |
| 0.5 |
1.5 |
GO:0042275 |
error-free postreplication DNA repair(GO:0042275) |
| 0.5 |
0.5 |
GO:0010847 |
regulation of chromatin assembly(GO:0010847) |
| 0.5 |
0.5 |
GO:2000382 |
positive regulation of mesoderm development(GO:2000382) |
| 0.5 |
0.5 |
GO:0036324 |
vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
| 0.5 |
1.4 |
GO:0002184 |
cytoplasmic translational termination(GO:0002184) |
| 0.5 |
1.9 |
GO:0002949 |
tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.5 |
2.8 |
GO:0000447 |
endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
| 0.5 |
1.4 |
GO:0071492 |
cellular response to UV-A(GO:0071492) |
| 0.5 |
2.7 |
GO:0006452 |
translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 0.5 |
1.4 |
GO:0071921 |
establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.4 |
1.8 |
GO:0030576 |
Cajal body organization(GO:0030576) |
| 0.4 |
1.3 |
GO:1903896 |
positive regulation of IRE1-mediated unfolded protein response(GO:1903896) |
| 0.4 |
1.3 |
GO:0015960 |
diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
| 0.4 |
8.5 |
GO:0000028 |
ribosomal small subunit assembly(GO:0000028) |
| 0.4 |
2.9 |
GO:0043951 |
negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.4 |
1.2 |
GO:0036388 |
pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
| 0.4 |
1.2 |
GO:0006420 |
arginyl-tRNA aminoacylation(GO:0006420) |
| 0.4 |
2.8 |
GO:2001199 |
negative regulation of dendritic cell differentiation(GO:2001199) |
| 0.4 |
1.2 |
GO:1901097 |
negative regulation of autophagosome maturation(GO:1901097) |
| 0.4 |
1.6 |
GO:0060715 |
syncytiotrophoblast cell differentiation involved in labyrinthine layer development(GO:0060715) |
| 0.4 |
1.6 |
GO:0071051 |
polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
| 0.4 |
0.4 |
GO:0008214 |
protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
| 0.4 |
2.3 |
GO:0060046 |
regulation of acrosome reaction(GO:0060046) |
| 0.4 |
1.5 |
GO:0038163 |
thrombopoietin-mediated signaling pathway(GO:0038163) |
| 0.4 |
1.5 |
GO:0043973 |
histone H3-K4 acetylation(GO:0043973) |
| 0.3 |
1.0 |
GO:0090071 |
negative regulation of ribosome biogenesis(GO:0090071) |
| 0.3 |
1.0 |
GO:0070476 |
rRNA (guanine-N7)-methylation(GO:0070476) |
| 0.3 |
1.0 |
GO:0006597 |
spermine biosynthetic process(GO:0006597) |
| 0.3 |
1.0 |
GO:1900060 |
negative regulation of ceramide biosynthetic process(GO:1900060) |
| 0.3 |
1.7 |
GO:0009052 |
pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
| 0.3 |
1.4 |
GO:1901069 |
guanosine-containing compound catabolic process(GO:1901069) |
| 0.3 |
2.0 |
GO:0039532 |
negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039532) |
| 0.3 |
1.0 |
GO:0075525 |
viral translational termination-reinitiation(GO:0075525) |
| 0.3 |
1.0 |
GO:0072106 |
regulation of ureteric bud formation(GO:0072106) positive regulation of ureteric bud formation(GO:0072107) |
| 0.3 |
1.0 |
GO:0061743 |
motor learning(GO:0061743) |
| 0.3 |
0.3 |
GO:0040009 |
regulation of growth rate(GO:0040009) |
| 0.3 |
0.3 |
GO:0072356 |
chromosome passenger complex localization to kinetochore(GO:0072356) |
| 0.3 |
1.9 |
GO:0072513 |
positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
| 0.3 |
1.2 |
GO:0044565 |
dendritic cell proliferation(GO:0044565) |
| 0.3 |
2.2 |
GO:0031145 |
anaphase-promoting complex-dependent catabolic process(GO:0031145) |
| 0.3 |
0.3 |
GO:0006244 |
pyrimidine nucleotide catabolic process(GO:0006244) pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
| 0.3 |
1.5 |
GO:0050651 |
dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
| 0.3 |
1.2 |
GO:0009597 |
detection of virus(GO:0009597) |
| 0.3 |
0.9 |
GO:0060598 |
dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis(GO:0060598) |
| 0.3 |
1.2 |
GO:1903378 |
positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.3 |
1.8 |
GO:0006123 |
mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.3 |
0.9 |
GO:0090289 |
regulation of osteoclast proliferation(GO:0090289) |
| 0.3 |
0.6 |
GO:0060676 |
ureteric bud formation(GO:0060676) |
| 0.3 |
0.9 |
GO:0071898 |
regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
| 0.3 |
0.9 |
GO:0003245 |
cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
| 0.3 |
0.3 |
GO:0043366 |
beta selection(GO:0043366) |
| 0.3 |
2.3 |
GO:0070474 |
positive regulation of uterine smooth muscle contraction(GO:0070474) |
| 0.3 |
1.7 |
GO:0070863 |
positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 0.3 |
2.0 |
GO:1900029 |
positive regulation of ruffle assembly(GO:1900029) |
| 0.3 |
1.1 |
GO:1902626 |
assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.3 |
0.8 |
GO:1901731 |
calcium-mediated signaling using extracellular calcium source(GO:0035585) positive regulation of platelet aggregation(GO:1901731) |
| 0.3 |
1.1 |
GO:0000957 |
mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
| 0.3 |
1.9 |
GO:0000022 |
mitotic spindle elongation(GO:0000022) mitotic spindle midzone assembly(GO:0051256) |
| 0.3 |
0.8 |
GO:2000642 |
negative regulation of early endosome to late endosome transport(GO:2000642) |
| 0.3 |
0.8 |
GO:0002538 |
arachidonic acid metabolite production involved in inflammatory response(GO:0002538) |
| 0.3 |
0.8 |
GO:1903774 |
positive regulation of viral budding via host ESCRT complex(GO:1903774) |
| 0.3 |
0.5 |
GO:1901228 |
positive regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901228) |
| 0.3 |
1.3 |
GO:0071985 |
multivesicular body sorting pathway(GO:0071985) |
| 0.3 |
0.3 |
GO:1901187 |
regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.3 |
2.1 |
GO:1900262 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.3 |
1.8 |
GO:0005981 |
regulation of glycogen catabolic process(GO:0005981) |
| 0.3 |
1.6 |
GO:0098734 |
protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
| 0.3 |
1.0 |
GO:0070537 |
histone H2A K63-linked deubiquitination(GO:0070537) |
| 0.3 |
1.0 |
GO:0018242 |
protein O-linked glycosylation via serine(GO:0018242) |
| 0.3 |
1.3 |
GO:1990928 |
response to amino acid starvation(GO:1990928) |
| 0.3 |
0.8 |
GO:0032511 |
late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
| 0.2 |
0.7 |
GO:0060244 |
negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 0.2 |
0.7 |
GO:0001732 |
formation of cytoplasmic translation initiation complex(GO:0001732) |
| 0.2 |
1.0 |
GO:0051643 |
endoplasmic reticulum localization(GO:0051643) |
| 0.2 |
1.0 |
GO:0045414 |
regulation of interleukin-8 biosynthetic process(GO:0045414) |
| 0.2 |
1.5 |
GO:0001302 |
replicative cell aging(GO:0001302) |
| 0.2 |
3.8 |
GO:0032927 |
positive regulation of activin receptor signaling pathway(GO:0032927) |
| 0.2 |
0.7 |
GO:1990046 |
positive regulation of mitochondrial DNA replication(GO:0090297) regulation of cardiolipin metabolic process(GO:1900208) positive regulation of cardiolipin metabolic process(GO:1900210) stress-induced mitochondrial fusion(GO:1990046) |
| 0.2 |
1.2 |
GO:0015867 |
ATP transport(GO:0015867) |
| 0.2 |
2.6 |
GO:0045899 |
positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
| 0.2 |
1.6 |
GO:0000920 |
cell separation after cytokinesis(GO:0000920) |
| 0.2 |
0.9 |
GO:0006933 |
negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
| 0.2 |
4.3 |
GO:0045116 |
protein neddylation(GO:0045116) |
| 0.2 |
1.1 |
GO:0006982 |
response to lipid hydroperoxide(GO:0006982) |
| 0.2 |
0.2 |
GO:0051036 |
regulation of endosome size(GO:0051036) |
| 0.2 |
1.1 |
GO:0071394 |
cellular response to testosterone stimulus(GO:0071394) |
| 0.2 |
0.7 |
GO:0072139 |
glomerular parietal epithelial cell differentiation(GO:0072139) |
| 0.2 |
1.5 |
GO:0001842 |
neural fold formation(GO:0001842) |
| 0.2 |
0.7 |
GO:0045900 |
negative regulation of translational elongation(GO:0045900) |
| 0.2 |
0.2 |
GO:1990379 |
lipid transport across blood brain barrier(GO:1990379) |
| 0.2 |
1.3 |
GO:0036444 |
calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.2 |
0.6 |
GO:1905005 |
regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905005) |
| 0.2 |
1.9 |
GO:0048742 |
regulation of skeletal muscle fiber development(GO:0048742) |
| 0.2 |
3.6 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.2 |
1.7 |
GO:1901970 |
positive regulation of mitotic sister chromatid separation(GO:1901970) |
| 0.2 |
2.1 |
GO:1903333 |
negative regulation of protein folding(GO:1903333) |
| 0.2 |
0.6 |
GO:0032918 |
polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
| 0.2 |
0.6 |
GO:0003376 |
sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
| 0.2 |
0.6 |
GO:0048698 |
negative regulation of collateral sprouting in absence of injury(GO:0048698) |
| 0.2 |
0.4 |
GO:0090237 |
regulation of arachidonic acid secretion(GO:0090237) positive regulation of arachidonic acid secretion(GO:0090238) |
| 0.2 |
0.6 |
GO:0097500 |
receptor localization to nonmotile primary cilium(GO:0097500) |
| 0.2 |
0.6 |
GO:1903232 |
melanosome assembly(GO:1903232) |
| 0.2 |
0.6 |
GO:1903722 |
regulation of centriole elongation(GO:1903722) |
| 0.2 |
3.0 |
GO:0008535 |
respiratory chain complex IV assembly(GO:0008535) |
| 0.2 |
7.5 |
GO:0000387 |
spliceosomal snRNP assembly(GO:0000387) |
| 0.2 |
1.6 |
GO:0060236 |
regulation of mitotic spindle organization(GO:0060236) |
| 0.2 |
0.8 |
GO:0015786 |
UDP-glucose transport(GO:0015786) |
| 0.2 |
2.2 |
GO:0006105 |
succinate metabolic process(GO:0006105) |
| 0.2 |
0.8 |
GO:0006547 |
histidine metabolic process(GO:0006547) |
| 0.2 |
0.8 |
GO:0072344 |
rescue of stalled ribosome(GO:0072344) |
| 0.2 |
0.6 |
GO:0006348 |
chromatin silencing at telomere(GO:0006348) |
| 0.2 |
0.6 |
GO:0090298 |
negative regulation of mitochondrial DNA replication(GO:0090298) |
| 0.2 |
1.7 |
GO:0006012 |
galactose metabolic process(GO:0006012) |
| 0.2 |
1.2 |
GO:1990564 |
protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
| 0.2 |
2.5 |
GO:0030953 |
astral microtubule organization(GO:0030953) |
| 0.2 |
0.4 |
GO:2000111 |
positive regulation of macrophage apoptotic process(GO:2000111) |
| 0.2 |
3.8 |
GO:0016226 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.2 |
0.6 |
GO:0061144 |
alveolar secondary septum development(GO:0061144) |
| 0.2 |
0.6 |
GO:0045472 |
response to ether(GO:0045472) |
| 0.2 |
4.0 |
GO:0007080 |
mitotic metaphase plate congression(GO:0007080) |
| 0.2 |
1.6 |
GO:0045719 |
negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
| 0.2 |
1.1 |
GO:1904217 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.2 |
0.2 |
GO:1903898 |
negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
| 0.2 |
4.3 |
GO:0000027 |
ribosomal large subunit assembly(GO:0000027) |
| 0.2 |
1.1 |
GO:0043137 |
DNA replication, removal of RNA primer(GO:0043137) |
| 0.2 |
1.2 |
GO:0007096 |
regulation of exit from mitosis(GO:0007096) |
| 0.2 |
0.5 |
GO:0032460 |
negative regulation of protein oligomerization(GO:0032460) negative regulation of protein homooligomerization(GO:0032463) |
| 0.2 |
1.4 |
GO:0070317 |
negative regulation of G0 to G1 transition(GO:0070317) |
| 0.2 |
0.5 |
GO:0035552 |
oxidative single-stranded DNA demethylation(GO:0035552) |
| 0.2 |
0.7 |
GO:0032382 |
positive regulation of intracellular lipid transport(GO:0032379) positive regulation of intracellular sterol transport(GO:0032382) positive regulation of intracellular cholesterol transport(GO:0032385) lipid hydroperoxide transport(GO:1901373) positive regulation of cholesterol import(GO:1904109) positive regulation of sterol import(GO:2000911) |
| 0.2 |
1.8 |
GO:0018065 |
protein-cofactor linkage(GO:0018065) |
| 0.2 |
0.3 |
GO:0090191 |
regulation of branch elongation involved in ureteric bud branching(GO:0072095) negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
| 0.2 |
0.7 |
GO:0002309 |
T cell proliferation involved in immune response(GO:0002309) |
| 0.2 |
0.5 |
GO:1903048 |
regulation of acetylcholine-gated cation channel activity(GO:1903048) |
| 0.2 |
0.3 |
GO:0033088 |
negative regulation of immature T cell proliferation in thymus(GO:0033088) |
| 0.2 |
0.5 |
GO:1902915 |
negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
| 0.2 |
0.2 |
GO:0033206 |
meiotic cytokinesis(GO:0033206) |
| 0.2 |
1.4 |
GO:0000729 |
DNA double-strand break processing(GO:0000729) |
| 0.2 |
2.2 |
GO:0030150 |
protein import into mitochondrial matrix(GO:0030150) |
| 0.2 |
0.7 |
GO:0006529 |
asparagine biosynthetic process(GO:0006529) |
| 0.2 |
2.4 |
GO:0009191 |
ribonucleoside diphosphate catabolic process(GO:0009191) |
| 0.2 |
1.3 |
GO:0032725 |
positive regulation of granulocyte macrophage colony-stimulating factor production(GO:0032725) |
| 0.2 |
1.5 |
GO:0051123 |
RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
| 0.2 |
0.7 |
GO:0072385 |
minus-end-directed organelle transport along microtubule(GO:0072385) |
| 0.2 |
0.5 |
GO:0046601 |
positive regulation of centriole replication(GO:0046601) |
| 0.2 |
0.5 |
GO:0030167 |
proteoglycan catabolic process(GO:0030167) |
| 0.2 |
0.3 |
GO:0090232 |
positive regulation of spindle checkpoint(GO:0090232) |
| 0.2 |
0.2 |
GO:1904251 |
regulation of bile acid metabolic process(GO:1904251) |
| 0.2 |
0.2 |
GO:0034427 |
nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
| 0.2 |
2.4 |
GO:0045948 |
positive regulation of translational initiation(GO:0045948) |
| 0.2 |
0.5 |
GO:0006269 |
DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.2 |
1.0 |
GO:2000672 |
negative regulation of motor neuron apoptotic process(GO:2000672) |
| 0.2 |
9.9 |
GO:0002181 |
cytoplasmic translation(GO:0002181) |
| 0.2 |
0.3 |
GO:0086103 |
G-protein coupled receptor signaling pathway involved in heart process(GO:0086103) |
| 0.2 |
0.8 |
GO:0072429 |
response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 0.2 |
1.4 |
GO:0031424 |
keratinization(GO:0031424) |
| 0.2 |
0.3 |
GO:1902109 |
negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
| 0.2 |
0.9 |
GO:0006621 |
protein retention in ER lumen(GO:0006621) |
| 0.2 |
0.5 |
GO:0030046 |
parallel actin filament bundle assembly(GO:0030046) |
| 0.2 |
0.5 |
GO:0009298 |
GDP-mannose biosynthetic process(GO:0009298) |
| 0.2 |
0.2 |
GO:0009106 |
lipoate metabolic process(GO:0009106) |
| 0.2 |
1.4 |
GO:0050765 |
negative regulation of phagocytosis(GO:0050765) |
| 0.2 |
0.8 |
GO:0046016 |
regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) positive regulation of transcription by glucose(GO:0046016) |
| 0.2 |
0.5 |
GO:0097475 |
motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
| 0.2 |
0.2 |
GO:1902807 |
negative regulation of cell cycle G1/S phase transition(GO:1902807) |
| 0.2 |
0.5 |
GO:0051030 |
snRNA transport(GO:0051030) |
| 0.2 |
0.6 |
GO:0021812 |
neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 0.1 |
0.6 |
GO:0035743 |
CD4-positive, alpha-beta T cell cytokine production(GO:0035743) T-helper 2 cell cytokine production(GO:0035745) |
| 0.1 |
1.5 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.1 |
1.0 |
GO:0007296 |
vitellogenesis(GO:0007296) |
| 0.1 |
0.9 |
GO:0045591 |
positive regulation of regulatory T cell differentiation(GO:0045591) |
| 0.1 |
0.1 |
GO:2000338 |
chemokine (C-X-C motif) ligand 1 production(GO:0072566) regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000338) |
| 0.1 |
3.5 |
GO:0015985 |
energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.1 |
0.3 |
GO:0060011 |
Sertoli cell proliferation(GO:0060011) |
| 0.1 |
0.7 |
GO:1903361 |
protein localization to basolateral plasma membrane(GO:1903361) |
| 0.1 |
0.4 |
GO:0046078 |
dUMP metabolic process(GO:0046078) |
| 0.1 |
0.3 |
GO:0007290 |
spermatid nucleus elongation(GO:0007290) |
| 0.1 |
2.0 |
GO:0051988 |
regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
| 0.1 |
1.3 |
GO:0042487 |
regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
| 0.1 |
1.0 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
| 0.1 |
0.6 |
GO:2001271 |
negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.1 |
0.4 |
GO:0038203 |
TORC2 signaling(GO:0038203) |
| 0.1 |
0.7 |
GO:0090666 |
scaRNA localization to Cajal body(GO:0090666) |
| 0.1 |
0.6 |
GO:0008340 |
determination of adult lifespan(GO:0008340) |
| 0.1 |
0.1 |
GO:0016259 |
selenocysteine metabolic process(GO:0016259) |
| 0.1 |
0.6 |
GO:1904263 |
positive regulation of TORC1 signaling(GO:1904263) |
| 0.1 |
0.1 |
GO:1903377 |
negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.1 |
0.3 |
GO:0010757 |
negative regulation of plasminogen activation(GO:0010757) |
| 0.1 |
0.4 |
GO:0046368 |
GDP-L-fucose metabolic process(GO:0046368) |
| 0.1 |
0.3 |
GO:0002578 |
negative regulation of antigen processing and presentation(GO:0002578) |
| 0.1 |
0.4 |
GO:0036091 |
positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 0.1 |
1.3 |
GO:1904153 |
negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.1 |
0.1 |
GO:0071930 |
negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
| 0.1 |
0.9 |
GO:0060666 |
dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.1 |
0.1 |
GO:0070072 |
vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.1 |
0.9 |
GO:0051310 |
metaphase plate congression(GO:0051310) |
| 0.1 |
3.3 |
GO:0000470 |
maturation of LSU-rRNA(GO:0000470) |
| 0.1 |
0.9 |
GO:1900037 |
regulation of cellular response to hypoxia(GO:1900037) |
| 0.1 |
0.3 |
GO:0006103 |
2-oxoglutarate metabolic process(GO:0006103) |
| 0.1 |
0.3 |
GO:0070897 |
DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
| 0.1 |
0.8 |
GO:0034316 |
negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
| 0.1 |
1.3 |
GO:1903504 |
regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
| 0.1 |
0.6 |
GO:0060923 |
cardiac muscle cell fate commitment(GO:0060923) |
| 0.1 |
1.4 |
GO:0051967 |
negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.1 |
0.8 |
GO:0010917 |
negative regulation of mitochondrial membrane potential(GO:0010917) |
| 0.1 |
0.3 |
GO:0070213 |
protein auto-ADP-ribosylation(GO:0070213) |
| 0.1 |
0.9 |
GO:0051418 |
interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.1 |
0.4 |
GO:0060672 |
epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.1 |
0.5 |
GO:0016540 |
protein autoprocessing(GO:0016540) |
| 0.1 |
0.4 |
GO:1905098 |
negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
| 0.1 |
1.0 |
GO:0060164 |
regulation of timing of neuron differentiation(GO:0060164) |
| 0.1 |
1.2 |
GO:0006995 |
cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.1 |
0.4 |
GO:0071169 |
establishment of protein localization to chromatin(GO:0071169) |
| 0.1 |
0.5 |
GO:2000304 |
positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
| 0.1 |
0.5 |
GO:0002337 |
B-1a B cell differentiation(GO:0002337) |
| 0.1 |
9.0 |
GO:0006413 |
translational initiation(GO:0006413) |
| 0.1 |
0.1 |
GO:2001270 |
regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) |
| 0.1 |
0.5 |
GO:0060066 |
oviduct development(GO:0060066) |
| 0.1 |
0.1 |
GO:0009193 |
pyrimidine ribonucleoside diphosphate metabolic process(GO:0009193) UDP metabolic process(GO:0046048) |
| 0.1 |
0.6 |
GO:0003433 |
chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
| 0.1 |
0.7 |
GO:1900028 |
negative regulation of ruffle assembly(GO:1900028) |
| 0.1 |
0.1 |
GO:0021593 |
rhombomere morphogenesis(GO:0021593) |
| 0.1 |
0.6 |
GO:1903215 |
negative regulation of protein targeting to mitochondrion(GO:1903215) |
| 0.1 |
0.4 |
GO:0033085 |
negative regulation of T cell differentiation in thymus(GO:0033085) |
| 0.1 |
0.2 |
GO:0099625 |
regulation of ventricular cardiac muscle cell membrane repolarization(GO:0060307) ventricular cardiac muscle cell membrane repolarization(GO:0099625) |
| 0.1 |
1.2 |
GO:0006020 |
inositol metabolic process(GO:0006020) |
| 0.1 |
0.2 |
GO:0071494 |
cellular response to UV-C(GO:0071494) |
| 0.1 |
0.6 |
GO:0003150 |
muscular septum morphogenesis(GO:0003150) |
| 0.1 |
2.3 |
GO:0010569 |
regulation of double-strand break repair via homologous recombination(GO:0010569) |
| 0.1 |
4.3 |
GO:0006284 |
base-excision repair(GO:0006284) |
| 0.1 |
0.2 |
GO:0006760 |
folic acid-containing compound metabolic process(GO:0006760) pteridine-containing compound metabolic process(GO:0042558) |
| 0.1 |
0.2 |
GO:0033030 |
negative regulation of neutrophil apoptotic process(GO:0033030) |
| 0.1 |
0.2 |
GO:0007341 |
penetration of zona pellucida(GO:0007341) |
| 0.1 |
0.4 |
GO:1903587 |
regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
| 0.1 |
0.2 |
GO:0033566 |
gamma-tubulin complex localization(GO:0033566) |
| 0.1 |
0.2 |
GO:2000987 |
positive regulation of fear response(GO:1903367) positive regulation of behavioral fear response(GO:2000987) |
| 0.1 |
0.4 |
GO:0001928 |
regulation of exocyst assembly(GO:0001928) |
| 0.1 |
0.6 |
GO:1901029 |
negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.1 |
0.2 |
GO:0043504 |
mitochondrial DNA repair(GO:0043504) |
| 0.1 |
0.1 |
GO:0033092 |
positive regulation of immature T cell proliferation in thymus(GO:0033092) |
| 0.1 |
1.0 |
GO:0035584 |
calcium-mediated signaling using intracellular calcium source(GO:0035584) |
| 0.1 |
1.3 |
GO:0061154 |
endothelial tube morphogenesis(GO:0061154) |
| 0.1 |
0.2 |
GO:0071603 |
endothelial cell-cell adhesion(GO:0071603) |
| 0.1 |
0.3 |
GO:0040018 |
positive regulation of multicellular organism growth(GO:0040018) |
| 0.1 |
1.0 |
GO:0019800 |
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.1 |
2.3 |
GO:0099517 |
anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
| 0.1 |
0.6 |
GO:0070125 |
mitochondrial translational elongation(GO:0070125) |
| 0.1 |
0.5 |
GO:1990086 |
lens fiber cell apoptotic process(GO:1990086) |
| 0.1 |
0.7 |
GO:0007021 |
tubulin complex assembly(GO:0007021) |
| 0.1 |
1.6 |
GO:0032515 |
negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.1 |
0.3 |
GO:1901896 |
positive regulation of calcium-transporting ATPase activity(GO:1901896) |
| 0.1 |
1.4 |
GO:0031268 |
pseudopodium organization(GO:0031268) |
| 0.1 |
1.2 |
GO:0051451 |
myoblast migration(GO:0051451) |
| 0.1 |
0.4 |
GO:0090148 |
membrane fission(GO:0090148) |
| 0.1 |
1.1 |
GO:0010824 |
regulation of centrosome duplication(GO:0010824) |
| 0.1 |
0.1 |
GO:0010936 |
negative regulation of macrophage cytokine production(GO:0010936) |
| 0.1 |
0.9 |
GO:1990173 |
protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
| 0.1 |
0.1 |
GO:2000407 |
regulation of T cell extravasation(GO:2000407) |
| 0.1 |
4.5 |
GO:0042274 |
ribosomal small subunit biogenesis(GO:0042274) |
| 0.1 |
0.3 |
GO:0015712 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.1 |
0.1 |
GO:1903960 |
negative regulation of anion transmembrane transport(GO:1903960) |
| 0.1 |
0.3 |
GO:0015889 |
cobalamin transport(GO:0015889) |
| 0.1 |
0.1 |
GO:1904706 |
negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
| 0.1 |
0.4 |
GO:2000392 |
regulation of lamellipodium morphogenesis(GO:2000392) positive regulation of lamellipodium morphogenesis(GO:2000394) |
| 0.1 |
0.3 |
GO:0052428 |
modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
| 0.1 |
1.2 |
GO:0060539 |
diaphragm development(GO:0060539) |
| 0.1 |
0.5 |
GO:0097411 |
hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.1 |
1.2 |
GO:0002693 |
positive regulation of cellular extravasation(GO:0002693) |
| 0.1 |
0.3 |
GO:0044778 |
meiotic DNA integrity checkpoint(GO:0044778) |
| 0.1 |
0.1 |
GO:0006106 |
fumarate metabolic process(GO:0006106) |
| 0.1 |
0.3 |
GO:0019255 |
glucose 1-phosphate metabolic process(GO:0019255) |
| 0.1 |
1.4 |
GO:0051382 |
kinetochore assembly(GO:0051382) |
| 0.1 |
0.6 |
GO:0042769 |
DNA damage response, detection of DNA damage(GO:0042769) |
| 0.1 |
2.2 |
GO:0070979 |
protein K11-linked ubiquitination(GO:0070979) |
| 0.1 |
0.3 |
GO:0090241 |
negative regulation of histone H4 acetylation(GO:0090241) |
| 0.1 |
0.2 |
GO:0035459 |
cargo loading into vesicle(GO:0035459) |
| 0.1 |
0.3 |
GO:0010499 |
proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.1 |
0.4 |
GO:0033314 |
mitotic DNA replication checkpoint(GO:0033314) |
| 0.1 |
0.5 |
GO:0036151 |
phosphatidylcholine acyl-chain remodeling(GO:0036151) |
| 0.1 |
0.4 |
GO:0019919 |
peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) peptidyl-arginine N-methylation(GO:0035246) peptidyl-arginine omega-N-methylation(GO:0035247) |
| 0.1 |
0.3 |
GO:0010764 |
negative regulation of fibroblast migration(GO:0010764) |
| 0.1 |
0.8 |
GO:0090141 |
positive regulation of mitochondrial fission(GO:0090141) |
| 0.1 |
0.2 |
GO:0018364 |
peptidyl-glutamine methylation(GO:0018364) |
| 0.1 |
0.3 |
GO:0000350 |
generation of catalytic spliceosome for second transesterification step(GO:0000350) |
| 0.1 |
0.6 |
GO:0098535 |
de novo centriole assembly(GO:0098535) |
| 0.1 |
0.5 |
GO:1902455 |
negative regulation of stem cell population maintenance(GO:1902455) |
| 0.1 |
0.4 |
GO:1903715 |
regulation of aerobic respiration(GO:1903715) |
| 0.1 |
0.2 |
GO:1902692 |
regulation of neuroblast proliferation(GO:1902692) |
| 0.1 |
0.6 |
GO:0001980 |
regulation of systemic arterial blood pressure by ischemic conditions(GO:0001980) |
| 0.1 |
0.1 |
GO:0090166 |
Golgi disassembly(GO:0090166) |
| 0.1 |
0.2 |
GO:1901492 |
positive regulation of lymphangiogenesis(GO:1901492) |
| 0.1 |
0.5 |
GO:0071205 |
clustering of voltage-gated potassium channels(GO:0045163) protein localization to juxtaparanode region of axon(GO:0071205) |
| 0.1 |
0.3 |
GO:0021849 |
neuroblast division in subventricular zone(GO:0021849) |
| 0.1 |
1.2 |
GO:0006614 |
SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.1 |
0.1 |
GO:1902548 |
negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
| 0.1 |
0.5 |
GO:0051126 |
negative regulation of actin nucleation(GO:0051126) |
| 0.1 |
0.9 |
GO:0006977 |
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
| 0.1 |
2.1 |
GO:0035855 |
megakaryocyte development(GO:0035855) |
| 0.1 |
0.4 |
GO:0032627 |
interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) |
| 0.1 |
0.5 |
GO:1900147 |
Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
| 0.1 |
1.1 |
GO:0015732 |
prostaglandin transport(GO:0015732) |
| 0.1 |
0.8 |
GO:0032211 |
negative regulation of telomere maintenance via telomerase(GO:0032211) |
| 0.1 |
0.4 |
GO:0051866 |
general adaptation syndrome(GO:0051866) |
| 0.1 |
0.8 |
GO:0006729 |
tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
| 0.1 |
0.4 |
GO:0000056 |
ribosomal small subunit export from nucleus(GO:0000056) |
| 0.1 |
0.1 |
GO:0071726 |
response to diacyl bacterial lipopeptide(GO:0071724) cellular response to diacyl bacterial lipopeptide(GO:0071726) |
| 0.1 |
0.5 |
GO:0018125 |
peptidyl-cysteine methylation(GO:0018125) |
| 0.1 |
0.1 |
GO:1904431 |
positive regulation of t-circle formation(GO:1904431) |
| 0.1 |
0.4 |
GO:0045213 |
neurotransmitter receptor metabolic process(GO:0045213) |
| 0.1 |
0.2 |
GO:0097155 |
fasciculation of sensory neuron axon(GO:0097155) |
| 0.1 |
1.0 |
GO:1990182 |
exosomal secretion(GO:1990182) |
| 0.1 |
0.6 |
GO:0071361 |
cellular response to ethanol(GO:0071361) |
| 0.1 |
0.3 |
GO:0001771 |
immunological synapse formation(GO:0001771) |
| 0.1 |
0.7 |
GO:0006122 |
mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.1 |
0.3 |
GO:0000733 |
DNA strand renaturation(GO:0000733) |
| 0.1 |
0.2 |
GO:1901642 |
purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
| 0.1 |
0.2 |
GO:0001866 |
NK T cell proliferation(GO:0001866) |
| 0.1 |
0.7 |
GO:0006004 |
fucose metabolic process(GO:0006004) |
| 0.1 |
0.2 |
GO:0006990 |
positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
| 0.1 |
0.9 |
GO:0034244 |
negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.1 |
0.1 |
GO:0010643 |
cell communication by chemical coupling(GO:0010643) |
| 0.1 |
1.1 |
GO:0008608 |
attachment of spindle microtubules to kinetochore(GO:0008608) |
| 0.1 |
1.9 |
GO:0030970 |
retrograde protein transport, ER to cytosol(GO:0030970) |
| 0.1 |
0.8 |
GO:0006183 |
GTP biosynthetic process(GO:0006183) |
| 0.1 |
4.2 |
GO:0006506 |
GPI anchor biosynthetic process(GO:0006506) |
| 0.1 |
0.2 |
GO:0035624 |
receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
| 0.1 |
0.3 |
GO:0061101 |
neuroendocrine cell differentiation(GO:0061101) |
| 0.1 |
0.1 |
GO:0052803 |
imidazole-containing compound metabolic process(GO:0052803) |
| 0.1 |
0.2 |
GO:2000157 |
regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
| 0.1 |
0.5 |
GO:0007386 |
compartment pattern specification(GO:0007386) |
| 0.1 |
0.7 |
GO:0090043 |
regulation of tubulin deacetylation(GO:0090043) |
| 0.1 |
3.8 |
GO:0043044 |
ATP-dependent chromatin remodeling(GO:0043044) |
| 0.1 |
0.1 |
GO:0070973 |
protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.1 |
0.3 |
GO:0060084 |
synaptic transmission involved in micturition(GO:0060084) |
| 0.1 |
0.4 |
GO:2000210 |
positive regulation of anoikis(GO:2000210) |
| 0.1 |
0.4 |
GO:0009212 |
dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate metabolic process(GO:0009211) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
| 0.1 |
0.2 |
GO:0000237 |
leptotene(GO:0000237) |
| 0.1 |
0.8 |
GO:0046784 |
viral mRNA export from host cell nucleus(GO:0046784) |
| 0.1 |
1.5 |
GO:0042744 |
hydrogen peroxide catabolic process(GO:0042744) |
| 0.1 |
0.7 |
GO:0070933 |
histone H4 deacetylation(GO:0070933) |
| 0.1 |
0.7 |
GO:0046826 |
negative regulation of protein export from nucleus(GO:0046826) |
| 0.1 |
0.3 |
GO:0035880 |
embryonic nail plate morphogenesis(GO:0035880) |
| 0.1 |
0.3 |
GO:0042256 |
mature ribosome assembly(GO:0042256) |
| 0.1 |
0.4 |
GO:0033632 |
regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
| 0.1 |
0.8 |
GO:0018230 |
peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.1 |
1.0 |
GO:0051882 |
mitochondrial depolarization(GO:0051882) |
| 0.1 |
0.3 |
GO:0042535 |
positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
| 0.1 |
0.3 |
GO:1903031 |
regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 0.1 |
0.5 |
GO:0071108 |
protein K48-linked deubiquitination(GO:0071108) |
| 0.1 |
0.9 |
GO:0061179 |
negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.1 |
0.1 |
GO:0002118 |
aggressive behavior(GO:0002118) |
| 0.1 |
0.6 |
GO:0090435 |
protein localization to nuclear envelope(GO:0090435) |
| 0.1 |
0.3 |
GO:0046618 |
drug export(GO:0046618) |
| 0.1 |
0.2 |
GO:0006083 |
acetate metabolic process(GO:0006083) |
| 0.1 |
0.4 |
GO:0006450 |
regulation of translational fidelity(GO:0006450) |
| 0.1 |
0.2 |
GO:2000043 |
regulation of cardiac cell fate specification(GO:2000043) |
| 0.1 |
0.3 |
GO:0006538 |
glutamate catabolic process(GO:0006538) |
| 0.1 |
3.7 |
GO:0032543 |
mitochondrial translation(GO:0032543) |
| 0.1 |
0.5 |
GO:0045003 |
DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
| 0.1 |
0.5 |
GO:1902897 |
regulation of postsynaptic density protein 95 clustering(GO:1902897) |
| 0.1 |
0.3 |
GO:1902416 |
positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
| 0.1 |
1.5 |
GO:0016180 |
snRNA processing(GO:0016180) |
| 0.1 |
0.5 |
GO:0003065 |
positive regulation of heart rate by epinephrine(GO:0003065) |
| 0.1 |
0.2 |
GO:2000353 |
positive regulation of endothelial cell apoptotic process(GO:2000353) |
| 0.1 |
0.3 |
GO:0035574 |
histone H4-K20 demethylation(GO:0035574) |
| 0.1 |
0.8 |
GO:0060124 |
positive regulation of growth hormone secretion(GO:0060124) |
| 0.1 |
0.2 |
GO:0045085 |
negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
| 0.1 |
3.3 |
GO:0010501 |
RNA secondary structure unwinding(GO:0010501) |
| 0.1 |
0.2 |
GO:0019673 |
GDP-mannose metabolic process(GO:0019673) |
| 0.1 |
0.2 |
GO:0060838 |
lymphatic endothelial cell fate commitment(GO:0060838) endothelial cell fate commitment(GO:0060839) regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
| 0.1 |
0.2 |
GO:1903800 |
positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
| 0.1 |
0.2 |
GO:0009838 |
abscission(GO:0009838) |
| 0.1 |
0.2 |
GO:0030261 |
chromosome condensation(GO:0030261) |
| 0.1 |
0.1 |
GO:0036353 |
histone H2A-K119 monoubiquitination(GO:0036353) |
| 0.1 |
0.4 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.1 |
0.3 |
GO:0010755 |
regulation of plasminogen activation(GO:0010755) |
| 0.1 |
0.1 |
GO:0015959 |
diadenosine polyphosphate metabolic process(GO:0015959) |
| 0.1 |
0.1 |
GO:1903519 |
apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
| 0.1 |
0.2 |
GO:0021649 |
vestibulocochlear nerve morphogenesis(GO:0021648) vestibulocochlear nerve structural organization(GO:0021649) cerebral cortex tangential migration using cell-axon interactions(GO:0021824) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) cranial ganglion development(GO:0061550) trigeminal ganglion development(GO:0061551) ganglion morphogenesis(GO:0061552) facioacoustic ganglion development(GO:1903375) dorsal root ganglion morphogenesis(GO:1904835) dorsal root ganglion development(GO:1990791) |
| 0.1 |
0.3 |
GO:0014722 |
regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
| 0.1 |
0.5 |
GO:0000963 |
mitochondrial RNA processing(GO:0000963) |
| 0.1 |
0.2 |
GO:0010958 |
regulation of amino acid import(GO:0010958) regulation of L-arginine import(GO:0010963) |
| 0.1 |
0.8 |
GO:0043046 |
DNA methylation involved in gamete generation(GO:0043046) |
| 0.1 |
0.4 |
GO:0090205 |
positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
| 0.1 |
0.1 |
GO:0033122 |
regulation of purine nucleotide catabolic process(GO:0033121) negative regulation of purine nucleotide catabolic process(GO:0033122) |
| 0.1 |
0.1 |
GO:0006545 |
glycine biosynthetic process(GO:0006545) |
| 0.1 |
0.2 |
GO:0009051 |
pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.1 |
0.3 |
GO:0051095 |
regulation of helicase activity(GO:0051095) |
| 0.1 |
0.3 |
GO:1902276 |
pancreatic amylase secretion(GO:0036395) regulation of pancreatic amylase secretion(GO:1902276) |
| 0.1 |
0.6 |
GO:0031571 |
mitotic G1 DNA damage checkpoint(GO:0031571) |
| 0.1 |
0.1 |
GO:0090035 |
regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
| 0.1 |
0.3 |
GO:0030223 |
neutrophil differentiation(GO:0030223) |
| 0.1 |
0.3 |
GO:2000383 |
regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
| 0.1 |
0.4 |
GO:0019896 |
axonal transport of mitochondrion(GO:0019896) |
| 0.1 |
0.4 |
GO:0060179 |
male mating behavior(GO:0060179) |
| 0.1 |
0.6 |
GO:0042989 |
sequestering of actin monomers(GO:0042989) |
| 0.1 |
0.5 |
GO:0042126 |
nitrate metabolic process(GO:0042126) |
| 0.1 |
0.4 |
GO:0034143 |
regulation of toll-like receptor 4 signaling pathway(GO:0034143) |
| 0.1 |
0.2 |
GO:0021553 |
olfactory nerve development(GO:0021553) |
| 0.1 |
0.2 |
GO:0045671 |
negative regulation of osteoclast differentiation(GO:0045671) |
| 0.1 |
0.2 |
GO:0015938 |
coenzyme A catabolic process(GO:0015938) nucleoside bisphosphate catabolic process(GO:0033869) ribonucleoside bisphosphate catabolic process(GO:0034031) purine nucleoside bisphosphate catabolic process(GO:0034034) |
| 0.1 |
0.5 |
GO:0090209 |
negative regulation of triglyceride metabolic process(GO:0090209) |
| 0.1 |
0.2 |
GO:0070172 |
positive regulation of tooth mineralization(GO:0070172) |
| 0.1 |
0.3 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
| 0.1 |
0.1 |
GO:0002385 |
organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
| 0.1 |
0.3 |
GO:0031509 |
telomeric heterochromatin assembly(GO:0031509) negative regulation of chromosome condensation(GO:1902340) |
| 0.1 |
0.1 |
GO:0034982 |
mitochondrial protein processing(GO:0034982) |
| 0.1 |
0.3 |
GO:0006432 |
phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.1 |
0.5 |
GO:0002679 |
respiratory burst involved in defense response(GO:0002679) |
| 0.1 |
0.2 |
GO:0006097 |
glyoxylate cycle(GO:0006097) |
| 0.1 |
0.4 |
GO:0034196 |
acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
| 0.1 |
0.2 |
GO:0019478 |
D-amino acid catabolic process(GO:0019478) |
| 0.1 |
0.2 |
GO:0070488 |
neutrophil aggregation(GO:0070488) |
| 0.1 |
0.2 |
GO:0030049 |
muscle filament sliding(GO:0030049) |
| 0.1 |
0.3 |
GO:0019355 |
nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.1 |
0.3 |
GO:0006742 |
NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
| 0.1 |
0.5 |
GO:2000348 |
regulation of CD40 signaling pathway(GO:2000348) |
| 0.1 |
0.2 |
GO:0071168 |
protein localization to chromatin(GO:0071168) |
| 0.1 |
0.5 |
GO:0061732 |
mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 0.1 |
0.2 |
GO:0071356 |
cellular response to tumor necrosis factor(GO:0071356) |
| 0.1 |
0.3 |
GO:0060340 |
positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
| 0.1 |
0.1 |
GO:0006544 |
glycine metabolic process(GO:0006544) |
| 0.1 |
0.4 |
GO:0071883 |
activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
| 0.1 |
0.4 |
GO:0009146 |
purine nucleoside triphosphate catabolic process(GO:0009146) |
| 0.1 |
0.3 |
GO:0030854 |
positive regulation of granulocyte differentiation(GO:0030854) |
| 0.1 |
0.2 |
GO:0070459 |
prolactin secretion(GO:0070459) |
| 0.1 |
0.2 |
GO:1902259 |
regulation of delayed rectifier potassium channel activity(GO:1902259) |
| 0.1 |
0.4 |
GO:0035331 |
negative regulation of hippo signaling(GO:0035331) |
| 0.1 |
0.1 |
GO:0060997 |
dendritic spine morphogenesis(GO:0060997) |
| 0.1 |
0.9 |
GO:0006699 |
bile acid biosynthetic process(GO:0006699) |
| 0.1 |
0.2 |
GO:0021691 |
cerebellar Purkinje cell layer maturation(GO:0021691) |
| 0.1 |
0.1 |
GO:0060453 |
regulation of gastric acid secretion(GO:0060453) |
| 0.1 |
0.7 |
GO:0060416 |
response to growth hormone(GO:0060416) |
| 0.1 |
0.4 |
GO:1902474 |
positive regulation of protein localization to synapse(GO:1902474) |
| 0.1 |
0.2 |
GO:0030647 |
polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
| 0.1 |
0.2 |
GO:0045925 |
positive regulation of female receptivity(GO:0045925) |
| 0.1 |
0.4 |
GO:0007220 |
Notch receptor processing(GO:0007220) |
| 0.1 |
0.3 |
GO:1903441 |
protein localization to ciliary membrane(GO:1903441) |
| 0.1 |
1.3 |
GO:0051127 |
positive regulation of actin nucleation(GO:0051127) |
| 0.1 |
0.1 |
GO:0032792 |
negative regulation of CREB transcription factor activity(GO:0032792) |
| 0.1 |
0.4 |
GO:0090502 |
RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
| 0.1 |
0.3 |
GO:0000076 |
DNA replication checkpoint(GO:0000076) |
| 0.1 |
0.1 |
GO:0044830 |
modulation by host of viral RNA genome replication(GO:0044830) |
| 0.1 |
0.2 |
GO:0035790 |
platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
| 0.1 |
0.4 |
GO:0032784 |
regulation of DNA-templated transcription, elongation(GO:0032784) |
| 0.1 |
1.7 |
GO:0045070 |
positive regulation of viral genome replication(GO:0045070) |
| 0.1 |
0.1 |
GO:0043255 |
regulation of carbohydrate biosynthetic process(GO:0043255) |
| 0.1 |
0.2 |
GO:0031055 |
chromatin remodeling at centromere(GO:0031055) |
| 0.1 |
0.9 |
GO:0007130 |
synaptonemal complex assembly(GO:0007130) synaptonemal complex organization(GO:0070193) |
| 0.1 |
0.1 |
GO:0006670 |
sphingosine metabolic process(GO:0006670) diol metabolic process(GO:0034311) sphingoid metabolic process(GO:0046519) |
| 0.1 |
0.1 |
GO:1902953 |
positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
| 0.1 |
0.8 |
GO:0006221 |
pyrimidine nucleotide biosynthetic process(GO:0006221) |
| 0.1 |
0.1 |
GO:0021960 |
anterior commissure morphogenesis(GO:0021960) |
| 0.1 |
0.6 |
GO:0045742 |
positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
| 0.1 |
0.1 |
GO:0050689 |
negative regulation of defense response to virus by host(GO:0050689) |
| 0.1 |
0.1 |
GO:0099612 |
protein localization to axon(GO:0099612) |
| 0.1 |
0.1 |
GO:0035511 |
oxidative DNA demethylation(GO:0035511) |
| 0.1 |
0.3 |
GO:1904707 |
regulation of vascular smooth muscle cell proliferation(GO:1904705) positive regulation of vascular smooth muscle cell proliferation(GO:1904707) vascular smooth muscle cell proliferation(GO:1990874) |
| 0.1 |
0.1 |
GO:0033313 |
meiotic cell cycle checkpoint(GO:0033313) |
| 0.1 |
0.3 |
GO:0090273 |
regulation of somatostatin secretion(GO:0090273) |
| 0.1 |
0.1 |
GO:0006526 |
arginine biosynthetic process(GO:0006526) |
| 0.1 |
2.2 |
GO:0009060 |
aerobic respiration(GO:0009060) |
| 0.1 |
0.3 |
GO:0006451 |
selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.1 |
0.1 |
GO:0072697 |
protein localization to cell cortex(GO:0072697) |
| 0.1 |
0.7 |
GO:0050901 |
leukocyte tethering or rolling(GO:0050901) |
| 0.1 |
0.2 |
GO:0006369 |
termination of RNA polymerase II transcription(GO:0006369) |
| 0.1 |
0.3 |
GO:0050862 |
positive regulation of T cell receptor signaling pathway(GO:0050862) |
| 0.1 |
0.4 |
GO:0008343 |
adult feeding behavior(GO:0008343) |
| 0.1 |
0.2 |
GO:0070345 |
negative regulation of fat cell proliferation(GO:0070345) |
| 0.1 |
0.3 |
GO:0015671 |
oxygen transport(GO:0015671) |
| 0.1 |
0.1 |
GO:0006307 |
DNA dealkylation involved in DNA repair(GO:0006307) |
| 0.1 |
0.4 |
GO:0033601 |
positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
| 0.1 |
0.7 |
GO:0006120 |
mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.1 |
0.4 |
GO:0000103 |
sulfate assimilation(GO:0000103) |
| 0.1 |
0.1 |
GO:0090086 |
negative regulation of protein deubiquitination(GO:0090086) |
| 0.1 |
0.5 |
GO:0045047 |
protein targeting to ER(GO:0045047) |
| 0.1 |
0.3 |
GO:0000491 |
small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
| 0.1 |
1.7 |
GO:0022900 |
electron transport chain(GO:0022900) |
| 0.1 |
0.2 |
GO:0009435 |
NAD biosynthetic process(GO:0009435) |
| 0.1 |
0.3 |
GO:0030263 |
apoptotic chromosome condensation(GO:0030263) |
| 0.1 |
0.5 |
GO:0032287 |
peripheral nervous system myelin maintenance(GO:0032287) |
| 0.1 |
0.7 |
GO:0060628 |
regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
| 0.1 |
0.2 |
GO:2000297 |
negative regulation of synapse maturation(GO:2000297) |
| 0.1 |
0.4 |
GO:0030644 |
cellular chloride ion homeostasis(GO:0030644) |
| 0.1 |
0.1 |
GO:0010225 |
response to UV-C(GO:0010225) |
| 0.1 |
0.4 |
GO:0009235 |
cobalamin metabolic process(GO:0009235) |
| 0.1 |
0.5 |
GO:0043162 |
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.1 |
0.6 |
GO:0050435 |
beta-amyloid metabolic process(GO:0050435) |
| 0.1 |
0.1 |
GO:0002925 |
positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
| 0.1 |
0.2 |
GO:0006546 |
glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.1 |
0.4 |
GO:0051461 |
regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
| 0.1 |
0.1 |
GO:0018343 |
protein farnesylation(GO:0018343) |
| 0.1 |
0.1 |
GO:0031038 |
myosin II filament organization(GO:0031038) regulation of myosin II filament organization(GO:0043519) |
| 0.1 |
0.3 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 0.1 |
0.2 |
GO:0006566 |
threonine metabolic process(GO:0006566) |
| 0.1 |
0.1 |
GO:0060743 |
epithelial cell maturation involved in prostate gland development(GO:0060743) |
| 0.1 |
4.6 |
GO:1903214 |
regulation of protein targeting to mitochondrion(GO:1903214) |
| 0.1 |
0.4 |
GO:0040016 |
embryonic cleavage(GO:0040016) |
| 0.1 |
0.1 |
GO:1902174 |
positive regulation of keratinocyte apoptotic process(GO:1902174) |
| 0.1 |
0.2 |
GO:0065001 |
negative regulation of histone H3-K36 methylation(GO:0000415) specification of axis polarity(GO:0065001) |
| 0.1 |
0.2 |
GO:0002710 |
negative regulation of T cell mediated immunity(GO:0002710) |
| 0.1 |
0.1 |
GO:0033615 |
mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
| 0.1 |
0.1 |
GO:2000189 |
positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.1 |
0.3 |
GO:0003383 |
apical constriction(GO:0003383) |
| 0.1 |
0.6 |
GO:0021796 |
cerebral cortex regionalization(GO:0021796) |
| 0.1 |
0.1 |
GO:2000286 |
receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 0.1 |
0.8 |
GO:0006879 |
cellular iron ion homeostasis(GO:0006879) |
| 0.1 |
0.2 |
GO:0070199 |
establishment of protein localization to chromosome(GO:0070199) |
| 0.1 |
0.1 |
GO:1903671 |
negative regulation of sprouting angiogenesis(GO:1903671) |
| 0.1 |
0.2 |
GO:0071459 |
protein localization to kinetochore(GO:0034501) protein localization to chromosome, centromeric region(GO:0071459) |
| 0.1 |
0.1 |
GO:0021590 |
cerebellum maturation(GO:0021590) cerebellar cortex maturation(GO:0021699) |
| 0.1 |
0.4 |
GO:0045647 |
negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.1 |
0.3 |
GO:0002862 |
negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
| 0.1 |
0.2 |
GO:1990034 |
calcium ion export from cell(GO:1990034) |
| 0.1 |
0.3 |
GO:2001022 |
positive regulation of response to DNA damage stimulus(GO:2001022) |
| 0.1 |
5.1 |
GO:0051028 |
mRNA transport(GO:0051028) |
| 0.1 |
0.6 |
GO:0061000 |
negative regulation of dendritic spine development(GO:0061000) |
| 0.1 |
1.2 |
GO:0031116 |
positive regulation of microtubule polymerization(GO:0031116) |
| 0.1 |
0.1 |
GO:0031584 |
activation of phospholipase D activity(GO:0031584) |
| 0.1 |
1.5 |
GO:0034723 |
DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.1 |
1.2 |
GO:0051298 |
centrosome duplication(GO:0051298) |
| 0.1 |
0.7 |
GO:0042346 |
positive regulation of NF-kappaB import into nucleus(GO:0042346) |
| 0.1 |
0.7 |
GO:0043470 |
regulation of carbohydrate catabolic process(GO:0043470) regulation of cellular carbohydrate catabolic process(GO:0043471) |
| 0.1 |
0.1 |
GO:0051582 |
positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
| 0.1 |
0.8 |
GO:0030224 |
monocyte differentiation(GO:0030224) |
| 0.1 |
0.1 |
GO:0046166 |
glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.1 |
0.1 |
GO:2000275 |
regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
| 0.1 |
0.7 |
GO:0036260 |
7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
| 0.1 |
0.2 |
GO:0034260 |
negative regulation of GTPase activity(GO:0034260) |
| 0.1 |
1.1 |
GO:0043029 |
T cell homeostasis(GO:0043029) |
| 0.1 |
0.2 |
GO:1900186 |
negative regulation of clathrin-mediated endocytosis(GO:1900186) |
| 0.1 |
0.1 |
GO:0051124 |
synaptic growth at neuromuscular junction(GO:0051124) |
| 0.1 |
0.1 |
GO:1902808 |
positive regulation of cell cycle G1/S phase transition(GO:1902808) |
| 0.1 |
0.1 |
GO:0000715 |
nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 0.1 |
0.3 |
GO:0045716 |
positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
| 0.1 |
0.2 |
GO:0048012 |
hepatocyte growth factor receptor signaling pathway(GO:0048012) |
| 0.1 |
0.3 |
GO:0031914 |
negative regulation of synaptic plasticity(GO:0031914) |
| 0.1 |
0.2 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 0.1 |
0.2 |
GO:2000781 |
positive regulation of double-strand break repair(GO:2000781) |
| 0.1 |
0.4 |
GO:0033211 |
adiponectin-activated signaling pathway(GO:0033211) |
| 0.1 |
0.1 |
GO:0007228 |
positive regulation of hh target transcription factor activity(GO:0007228) |
| 0.1 |
0.9 |
GO:0045739 |
positive regulation of DNA repair(GO:0045739) |
| 0.1 |
0.2 |
GO:0071680 |
response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
| 0.1 |
0.2 |
GO:1900220 |
semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.1 |
0.4 |
GO:0006968 |
cellular defense response(GO:0006968) |
| 0.1 |
0.2 |
GO:1902219 |
regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
| 0.1 |
6.1 |
GO:0043484 |
regulation of RNA splicing(GO:0043484) |
| 0.1 |
0.6 |
GO:0006654 |
phosphatidic acid biosynthetic process(GO:0006654) phosphatidic acid metabolic process(GO:0046473) |
| 0.1 |
0.4 |
GO:1900194 |
negative regulation of oocyte maturation(GO:1900194) |
| 0.1 |
0.2 |
GO:0008616 |
queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.0 |
0.6 |
GO:1902254 |
negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902254) |
| 0.0 |
0.0 |
GO:0061032 |
visceral serous pericardium development(GO:0061032) |
| 0.0 |
0.4 |
GO:0032506 |
cytokinetic process(GO:0032506) |
| 0.0 |
0.1 |
GO:0010871 |
negative regulation of receptor biosynthetic process(GO:0010871) |
| 0.0 |
0.6 |
GO:0000394 |
RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) |
| 0.0 |
1.9 |
GO:0006626 |
protein targeting to mitochondrion(GO:0006626) |
| 0.0 |
0.1 |
GO:1900017 |
positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.0 |
0.4 |
GO:0007042 |
lysosomal lumen acidification(GO:0007042) |
| 0.0 |
0.3 |
GO:0006398 |
mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.0 |
0.3 |
GO:2000009 |
negative regulation of protein localization to cell surface(GO:2000009) |
| 0.0 |
0.3 |
GO:0002002 |
regulation of angiotensin levels in blood(GO:0002002) |
| 0.0 |
0.1 |
GO:0031118 |
rRNA pseudouridine synthesis(GO:0031118) |
| 0.0 |
0.1 |
GO:0001978 |
regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) |
| 0.0 |
0.3 |
GO:0035948 |
positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
| 0.0 |
0.4 |
GO:0021678 |
third ventricle development(GO:0021678) |
| 0.0 |
0.1 |
GO:1901727 |
positive regulation of histone deacetylase activity(GO:1901727) |
| 0.0 |
0.1 |
GO:0070782 |
phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
| 0.0 |
0.1 |
GO:0043456 |
regulation of pentose-phosphate shunt(GO:0043456) |
| 0.0 |
0.5 |
GO:0048642 |
negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.0 |
0.1 |
GO:0072677 |
eosinophil chemotaxis(GO:0048245) eosinophil migration(GO:0072677) |
| 0.0 |
0.2 |
GO:1903300 |
negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.0 |
0.5 |
GO:0007413 |
axonal fasciculation(GO:0007413) |
| 0.0 |
0.2 |
GO:0015819 |
lysine transport(GO:0015819) |
| 0.0 |
0.2 |
GO:2000252 |
negative regulation of feeding behavior(GO:2000252) |
| 0.0 |
0.3 |
GO:0010459 |
negative regulation of heart rate(GO:0010459) |
| 0.0 |
0.1 |
GO:0046294 |
formaldehyde catabolic process(GO:0046294) |
| 0.0 |
0.5 |
GO:0030836 |
positive regulation of actin filament depolymerization(GO:0030836) |
| 0.0 |
1.4 |
GO:0070303 |
negative regulation of stress-activated MAPK cascade(GO:0032873) negative regulation of stress-activated protein kinase signaling cascade(GO:0070303) |
| 0.0 |
0.2 |
GO:2000270 |
negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.0 |
0.4 |
GO:0048199 |
vesicle targeting, to, from or within Golgi(GO:0048199) |
| 0.0 |
0.2 |
GO:0035860 |
glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
| 0.0 |
0.6 |
GO:0051764 |
actin crosslink formation(GO:0051764) |
| 0.0 |
0.1 |
GO:0072217 |
mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003337) negative regulation of metanephros development(GO:0072217) |
| 0.0 |
0.4 |
GO:0018916 |
nitrobenzene metabolic process(GO:0018916) |
| 0.0 |
0.2 |
GO:0048701 |
embryonic cranial skeleton morphogenesis(GO:0048701) |
| 0.0 |
0.2 |
GO:1903288 |
regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
| 0.0 |
0.0 |
GO:0042516 |
tyrosine phosphorylation of Stat3 protein(GO:0042503) regulation of tyrosine phosphorylation of Stat3 protein(GO:0042516) |
| 0.0 |
0.2 |
GO:0032000 |
positive regulation of fatty acid beta-oxidation(GO:0032000) |
| 0.0 |
0.1 |
GO:0010606 |
positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.0 |
0.1 |
GO:2000620 |
positive regulation of histone H4-K16 acetylation(GO:2000620) |
| 0.0 |
0.1 |
GO:0006116 |
NADH oxidation(GO:0006116) |
| 0.0 |
0.1 |
GO:0035094 |
response to nicotine(GO:0035094) |
| 0.0 |
0.1 |
GO:0016332 |
establishment or maintenance of polarity of embryonic epithelium(GO:0016332) |
| 0.0 |
0.7 |
GO:0021516 |
dorsal spinal cord development(GO:0021516) |
| 0.0 |
0.1 |
GO:0060025 |
regulation of synaptic activity(GO:0060025) |
| 0.0 |
0.3 |
GO:0051085 |
chaperone mediated protein folding requiring cofactor(GO:0051085) |
| 0.0 |
0.1 |
GO:0048241 |
epinephrine transport(GO:0048241) epinephrine secretion(GO:0048242) |
| 0.0 |
0.3 |
GO:0006501 |
C-terminal protein lipidation(GO:0006501) |
| 0.0 |
0.3 |
GO:0006607 |
NLS-bearing protein import into nucleus(GO:0006607) |
| 0.0 |
0.6 |
GO:0043388 |
positive regulation of DNA binding(GO:0043388) |
| 0.0 |
0.5 |
GO:0002227 |
innate immune response in mucosa(GO:0002227) |
| 0.0 |
0.2 |
GO:0010387 |
COP9 signalosome assembly(GO:0010387) |
| 0.0 |
0.2 |
GO:1900095 |
regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
| 0.0 |
0.1 |
GO:0060741 |
prostate gland stromal morphogenesis(GO:0060741) |
| 0.0 |
1.2 |
GO:0033209 |
tumor necrosis factor-mediated signaling pathway(GO:0033209) |
| 0.0 |
0.1 |
GO:0002326 |
B cell lineage commitment(GO:0002326) |
| 0.0 |
0.1 |
GO:0072592 |
oxygen metabolic process(GO:0072592) |
| 0.0 |
0.1 |
GO:0030300 |
regulation of intestinal cholesterol absorption(GO:0030300) |
| 0.0 |
0.1 |
GO:0097201 |
negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
| 0.0 |
0.1 |
GO:1903332 |
regulation of protein folding(GO:1903332) |
| 0.0 |
0.1 |
GO:0032780 |
negative regulation of ATPase activity(GO:0032780) |
| 0.0 |
0.1 |
GO:0048211 |
Golgi vesicle docking(GO:0048211) |
| 0.0 |
0.1 |
GO:0032916 |
transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) positive regulation of transforming growth factor beta3 production(GO:0032916) activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
| 0.0 |
0.5 |
GO:0032525 |
somite rostral/caudal axis specification(GO:0032525) |
| 0.0 |
0.1 |
GO:0001788 |
antibody-dependent cellular cytotoxicity(GO:0001788) |
| 0.0 |
0.2 |
GO:0010739 |
positive regulation of protein kinase A signaling(GO:0010739) |
| 0.0 |
0.3 |
GO:0061299 |
retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.0 |
0.1 |
GO:0010920 |
negative regulation of inositol phosphate biosynthetic process(GO:0010920) testosterone biosynthetic process(GO:0061370) regulation of testosterone biosynthetic process(GO:2000224) |
| 0.0 |
0.2 |
GO:0014029 |
neural crest formation(GO:0014029) |
| 0.0 |
0.5 |
GO:0050832 |
defense response to fungus(GO:0050832) |
| 0.0 |
0.1 |
GO:0006532 |
aspartate biosynthetic process(GO:0006532) |
| 0.0 |
0.1 |
GO:0006564 |
L-serine biosynthetic process(GO:0006564) |
| 0.0 |
0.1 |
GO:0001921 |
positive regulation of receptor recycling(GO:0001921) |
| 0.0 |
0.5 |
GO:2000279 |
negative regulation of DNA biosynthetic process(GO:2000279) |
| 0.0 |
0.1 |
GO:0009957 |
epidermal cell fate specification(GO:0009957) |
| 0.0 |
1.5 |
GO:0042461 |
photoreceptor cell development(GO:0042461) |
| 0.0 |
0.2 |
GO:1902231 |
positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.0 |
0.2 |
GO:0070935 |
3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.0 |
0.5 |
GO:0040034 |
regulation of development, heterochronic(GO:0040034) |
| 0.0 |
0.6 |
GO:0071539 |
protein localization to centrosome(GO:0071539) |
| 0.0 |
0.1 |
GO:0036344 |
platelet morphogenesis(GO:0036344) |
| 0.0 |
0.1 |
GO:0035902 |
response to immobilization stress(GO:0035902) |
| 0.0 |
0.2 |
GO:0033631 |
cell-cell adhesion mediated by integrin(GO:0033631) |
| 0.0 |
0.2 |
GO:0002692 |
negative regulation of cellular extravasation(GO:0002692) |
| 0.0 |
0.5 |
GO:0033866 |
coenzyme A biosynthetic process(GO:0015937) nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
| 0.0 |
0.4 |
GO:1902857 |
positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.0 |
0.0 |
GO:0010390 |
histone monoubiquitination(GO:0010390) |
| 0.0 |
0.1 |
GO:0002408 |
myeloid dendritic cell chemotaxis(GO:0002408) |
| 0.0 |
0.1 |
GO:0086017 |
Purkinje myocyte action potential(GO:0086017) Purkinje myocyte to ventricular cardiac muscle cell signaling(GO:0086029) Purkinje myocyte to ventricular cardiac muscle cell communication(GO:0086068) |
| 0.0 |
0.1 |
GO:1902498 |
regulation of protein K63-linked ubiquitination(GO:1900044) regulation of protein autoubiquitination(GO:1902498) |
| 0.0 |
0.2 |
GO:0010592 |
positive regulation of lamellipodium assembly(GO:0010592) |
| 0.0 |
0.5 |
GO:0038092 |
nodal signaling pathway(GO:0038092) |
| 0.0 |
0.5 |
GO:0032781 |
positive regulation of ATPase activity(GO:0032781) |
| 0.0 |
0.1 |
GO:0032292 |
myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
| 0.0 |
0.1 |
GO:0070318 |
positive regulation of G0 to G1 transition(GO:0070318) |
| 0.0 |
1.4 |
GO:0070527 |
platelet aggregation(GO:0070527) |
| 0.0 |
0.1 |
GO:0015936 |
coenzyme A metabolic process(GO:0015936) |
| 0.0 |
0.0 |
GO:0003221 |
right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
| 0.0 |
0.2 |
GO:0046836 |
glycolipid transport(GO:0046836) |
| 0.0 |
0.1 |
GO:1990705 |
cholangiocyte proliferation(GO:1990705) |
| 0.0 |
0.4 |
GO:0071353 |
cellular response to interleukin-4(GO:0071353) |
| 0.0 |
0.1 |
GO:2000983 |
regulation of ATP citrate synthase activity(GO:2000983) negative regulation of ATP citrate synthase activity(GO:2000984) |
| 0.0 |
0.1 |
GO:0072599 |
establishment of protein localization to endoplasmic reticulum(GO:0072599) |
| 0.0 |
0.3 |
GO:0048096 |
chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.0 |
0.1 |
GO:0002051 |
osteoblast fate commitment(GO:0002051) |
| 0.0 |
0.0 |
GO:0035519 |
protein K29-linked ubiquitination(GO:0035519) |
| 0.0 |
0.4 |
GO:0035518 |
histone H2A monoubiquitination(GO:0035518) |
| 0.0 |
0.2 |
GO:0002934 |
desmosome organization(GO:0002934) |
| 0.0 |
0.1 |
GO:0000727 |
double-strand break repair via break-induced replication(GO:0000727) |
| 0.0 |
0.2 |
GO:0045987 |
positive regulation of smooth muscle contraction(GO:0045987) |
| 0.0 |
0.1 |
GO:0002755 |
MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
| 0.0 |
0.2 |
GO:2000001 |
regulation of DNA damage checkpoint(GO:2000001) |
| 0.0 |
0.4 |
GO:0006900 |
membrane budding(GO:0006900) |
| 0.0 |
0.1 |
GO:0042360 |
vitamin E metabolic process(GO:0042360) |
| 0.0 |
0.3 |
GO:0042492 |
gamma-delta T cell differentiation(GO:0042492) |
| 0.0 |
0.1 |
GO:0032924 |
activin receptor signaling pathway(GO:0032924) |
| 0.0 |
0.1 |
GO:0060766 |
negative regulation of androgen receptor signaling pathway(GO:0060766) |
| 0.0 |
0.1 |
GO:0032049 |
cardiolipin biosynthetic process(GO:0032049) |
| 0.0 |
0.2 |
GO:0071476 |
cellular hypotonic response(GO:0071476) |
| 0.0 |
0.9 |
GO:0045494 |
photoreceptor cell maintenance(GO:0045494) |
| 0.0 |
0.0 |
GO:0042483 |
negative regulation of odontogenesis(GO:0042483) |
| 0.0 |
0.1 |
GO:0061086 |
negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.0 |
0.1 |
GO:0007084 |
mitotic nuclear envelope reassembly(GO:0007084) |
| 0.0 |
0.3 |
GO:0045176 |
apical protein localization(GO:0045176) |
| 0.0 |
0.7 |
GO:0003301 |
physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.0 |
0.1 |
GO:0044351 |
macropinocytosis(GO:0044351) |
| 0.0 |
0.5 |
GO:0032968 |
positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
| 0.0 |
0.3 |
GO:0006367 |
transcription initiation from RNA polymerase II promoter(GO:0006367) |
| 0.0 |
0.2 |
GO:0032435 |
negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) |
| 0.0 |
0.1 |
GO:0035356 |
cellular triglyceride homeostasis(GO:0035356) |
| 0.0 |
0.6 |
GO:0010842 |
retina layer formation(GO:0010842) |
| 0.0 |
0.1 |
GO:0061073 |
ciliary body morphogenesis(GO:0061073) |
| 0.0 |
0.2 |
GO:0032485 |
regulation of Ral protein signal transduction(GO:0032485) |
| 0.0 |
0.4 |
GO:0006828 |
manganese ion transport(GO:0006828) |
| 0.0 |
0.2 |
GO:1903755 |
regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
| 0.0 |
10.6 |
GO:0006412 |
translation(GO:0006412) |
| 0.0 |
0.1 |
GO:2000676 |
positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 0.0 |
0.9 |
GO:0008299 |
isoprenoid biosynthetic process(GO:0008299) |
| 0.0 |
0.1 |
GO:0060334 |
regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 0.0 |
0.2 |
GO:0021854 |
hypothalamus development(GO:0021854) |
| 0.0 |
0.4 |
GO:0045648 |
positive regulation of erythrocyte differentiation(GO:0045648) |
| 0.0 |
0.1 |
GO:0036112 |
medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
| 0.0 |
0.1 |
GO:1903966 |
monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.0 |
0.2 |
GO:0051152 |
positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.0 |
0.1 |
GO:0002842 |
T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) positive regulation of T cell mediated immune response to tumor cell(GO:0002842) |
| 0.0 |
0.2 |
GO:0045603 |
positive regulation of endothelial cell differentiation(GO:0045603) |
| 0.0 |
0.3 |
GO:1902850 |
mitotic spindle assembly(GO:0090307) microtubule cytoskeleton organization involved in mitosis(GO:1902850) |
| 0.0 |
0.1 |
GO:0001580 |
detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
| 0.0 |
0.5 |
GO:0051225 |
spindle assembly(GO:0051225) |
| 0.0 |
0.1 |
GO:0033363 |
secretory granule organization(GO:0033363) |
| 0.0 |
0.1 |
GO:0008089 |
anterograde axonal transport(GO:0008089) |
| 0.0 |
0.2 |
GO:0070207 |
protein homotrimerization(GO:0070207) |
| 0.0 |
0.1 |
GO:0071447 |
cellular response to hydroperoxide(GO:0071447) |
| 0.0 |
0.1 |
GO:0000289 |
nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
| 0.0 |
0.1 |
GO:0071609 |
chemokine (C-C motif) ligand 5 production(GO:0071609) |
| 0.0 |
1.3 |
GO:2000045 |
regulation of G1/S transition of mitotic cell cycle(GO:2000045) |
| 0.0 |
0.1 |
GO:0022615 |
protein to membrane docking(GO:0022615) |
| 0.0 |
0.3 |
GO:0042407 |
cristae formation(GO:0042407) |
| 0.0 |
0.6 |
GO:0061028 |
establishment of endothelial barrier(GO:0061028) |
| 0.0 |
0.3 |
GO:0050819 |
negative regulation of coagulation(GO:0050819) |
| 0.0 |
0.6 |
GO:0031146 |
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.0 |
0.2 |
GO:0071493 |
cellular response to UV-B(GO:0071493) |
| 0.0 |
0.4 |
GO:0008631 |
intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
| 0.0 |
0.2 |
GO:0038030 |
non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 0.0 |
0.0 |
GO:0044774 |
mitotic DNA integrity checkpoint(GO:0044774) |
| 0.0 |
0.3 |
GO:0001946 |
lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
| 0.0 |
0.1 |
GO:0014005 |
microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.0 |
0.0 |
GO:2000574 |
regulation of microtubule motor activity(GO:2000574) |
| 0.0 |
0.1 |
GO:0007171 |
activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.0 |
0.2 |
GO:0010719 |
negative regulation of epithelial to mesenchymal transition(GO:0010719) |
| 0.0 |
0.1 |
GO:0032367 |
intracellular cholesterol transport(GO:0032367) |
| 0.0 |
0.3 |
GO:0000188 |
inactivation of MAPK activity(GO:0000188) |
| 0.0 |
0.1 |
GO:1901740 |
negative regulation of myoblast fusion(GO:1901740) |
| 0.0 |
0.1 |
GO:0051383 |
kinetochore organization(GO:0051383) |
| 0.0 |
0.4 |
GO:0007274 |
neuromuscular synaptic transmission(GO:0007274) |
| 0.0 |
0.1 |
GO:0010735 |
positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.0 |
0.0 |
GO:0039530 |
MDA-5 signaling pathway(GO:0039530) |
| 0.0 |
0.1 |
GO:0060486 |
Clara cell differentiation(GO:0060486) |
| 0.0 |
0.2 |
GO:0035987 |
endodermal cell differentiation(GO:0035987) |
| 0.0 |
0.1 |
GO:0043649 |
dicarboxylic acid catabolic process(GO:0043649) |
| 0.0 |
0.1 |
GO:0006999 |
nuclear pore organization(GO:0006999) |
| 0.0 |
0.2 |
GO:0046502 |
uroporphyrinogen III metabolic process(GO:0046502) |
| 0.0 |
0.1 |
GO:0021913 |
regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
| 0.0 |
0.0 |
GO:0060339 |
negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
| 0.0 |
0.1 |
GO:0043457 |
regulation of cellular respiration(GO:0043457) |
| 0.0 |
0.1 |
GO:2000467 |
positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 0.0 |
0.1 |
GO:0042097 |
interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
| 0.0 |
0.3 |
GO:0006560 |
proline metabolic process(GO:0006560) |
| 0.0 |
0.1 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.0 |
0.2 |
GO:0042092 |
regulation of type 2 immune response(GO:0002828) type 2 immune response(GO:0042092) |
| 0.0 |
0.1 |
GO:0046898 |
response to cycloheximide(GO:0046898) |
| 0.0 |
0.0 |
GO:0032786 |
positive regulation of DNA-templated transcription, elongation(GO:0032786) |
| 0.0 |
0.3 |
GO:0031648 |
protein destabilization(GO:0031648) |
| 0.0 |
0.2 |
GO:0021730 |
trigeminal sensory nucleus development(GO:0021730) principal sensory nucleus of trigeminal nerve development(GO:0021740) |
| 0.0 |
0.1 |
GO:0007320 |
insemination(GO:0007320) |
| 0.0 |
0.1 |
GO:0034393 |
positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
| 0.0 |
0.5 |
GO:0010633 |
negative regulation of epithelial cell migration(GO:0010633) |
| 0.0 |
0.3 |
GO:0019262 |
N-acetylneuraminate catabolic process(GO:0019262) |
| 0.0 |
0.2 |
GO:0061635 |
regulation of protein complex stability(GO:0061635) |
| 0.0 |
0.2 |
GO:0035735 |
intraciliary transport involved in cilium morphogenesis(GO:0035735) |
| 0.0 |
0.1 |
GO:0006071 |
glycerol metabolic process(GO:0006071) |
| 0.0 |
0.8 |
GO:0050830 |
defense response to Gram-positive bacterium(GO:0050830) |
| 0.0 |
0.4 |
GO:0045722 |
positive regulation of gluconeogenesis(GO:0045722) |
| 0.0 |
0.1 |
GO:2000310 |
regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
| 0.0 |
0.1 |
GO:0072318 |
clathrin coat disassembly(GO:0072318) |
| 0.0 |
0.4 |
GO:0018345 |
protein palmitoylation(GO:0018345) |
| 0.0 |
0.2 |
GO:1904587 |
glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
| 0.0 |
0.1 |
GO:1901837 |
negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
| 0.0 |
0.1 |
GO:0050748 |
negative regulation of lipoprotein metabolic process(GO:0050748) |
| 0.0 |
0.2 |
GO:0045663 |
positive regulation of myoblast differentiation(GO:0045663) |
| 0.0 |
0.1 |
GO:0050957 |
equilibrioception(GO:0050957) |
| 0.0 |
0.4 |
GO:0033108 |
mitochondrial respiratory chain complex assembly(GO:0033108) |
| 0.0 |
0.2 |
GO:0071786 |
endoplasmic reticulum tubular network organization(GO:0071786) |
| 0.0 |
0.3 |
GO:0021511 |
spinal cord patterning(GO:0021511) |
| 0.0 |
0.2 |
GO:0071260 |
cellular response to mechanical stimulus(GO:0071260) |
| 0.0 |
0.0 |
GO:0009786 |
regulation of asymmetric cell division(GO:0009786) |
| 0.0 |
0.1 |
GO:0006730 |
one-carbon metabolic process(GO:0006730) |
| 0.0 |
0.0 |
GO:0006824 |
cobalt ion transport(GO:0006824) |
| 0.0 |
0.1 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
| 0.0 |
0.2 |
GO:0000059 |
protein import into nucleus, docking(GO:0000059) |
| 0.0 |
0.0 |
GO:0014063 |
negative regulation of serotonin secretion(GO:0014063) |
| 0.0 |
0.0 |
GO:0010626 |
negative regulation of Schwann cell proliferation(GO:0010626) |
| 0.0 |
0.0 |
GO:0051562 |
negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 0.0 |
0.0 |
GO:0001951 |
intestinal D-glucose absorption(GO:0001951) terminal web assembly(GO:1902896) |
| 0.0 |
0.1 |
GO:0002940 |
tRNA N2-guanine methylation(GO:0002940) |
| 0.0 |
0.1 |
GO:0046125 |
pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
| 0.0 |
0.5 |
GO:2000179 |
positive regulation of neural precursor cell proliferation(GO:2000179) |
| 0.0 |
0.1 |
GO:0046037 |
GMP metabolic process(GO:0046037) |
| 0.0 |
0.1 |
GO:0042219 |
cellular modified amino acid catabolic process(GO:0042219) |
| 0.0 |
0.4 |
GO:0042168 |
heme metabolic process(GO:0042168) |
| 0.0 |
0.1 |
GO:0000279 |
mitotic M phase(GO:0000087) M phase(GO:0000279) mitotic cell cycle phase(GO:0098763) |
| 0.0 |
0.3 |
GO:0009438 |
methylglyoxal metabolic process(GO:0009438) |
| 0.0 |
0.2 |
GO:0050434 |
positive regulation of viral transcription(GO:0050434) |
| 0.0 |
0.1 |
GO:0019695 |
choline metabolic process(GO:0019695) |
| 0.0 |
0.1 |
GO:0033280 |
response to vitamin D(GO:0033280) |
| 0.0 |
0.1 |
GO:1903608 |
protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.0 |
0.0 |
GO:0060700 |
regulation of ribonuclease activity(GO:0060700) |
| 0.0 |
0.2 |
GO:0045943 |
positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
| 0.0 |
0.0 |
GO:0002645 |
positive regulation of tolerance induction(GO:0002645) positive regulation of T cell tolerance induction(GO:0002666) regulation of alpha-beta T cell proliferation(GO:0046640) negative regulation of alpha-beta T cell proliferation(GO:0046642) |
| 0.0 |
0.2 |
GO:0030238 |
male sex determination(GO:0030238) |
| 0.0 |
0.1 |
GO:0046697 |
decidualization(GO:0046697) |
| 0.0 |
0.2 |
GO:0050774 |
negative regulation of dendrite morphogenesis(GO:0050774) |
| 0.0 |
0.2 |
GO:0043101 |
purine-containing compound salvage(GO:0043101) |
| 0.0 |
0.1 |
GO:0050910 |
detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
| 0.0 |
0.2 |
GO:0061302 |
smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.0 |
0.0 |
GO:0070914 |
UV-damage excision repair(GO:0070914) |
| 0.0 |
0.1 |
GO:0001837 |
epithelial to mesenchymal transition(GO:0001837) |
| 0.0 |
3.4 |
GO:0008380 |
RNA splicing(GO:0008380) |
| 0.0 |
0.1 |
GO:2000194 |
regulation of female gonad development(GO:2000194) |
| 0.0 |
0.1 |
GO:2000060 |
positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
| 0.0 |
0.2 |
GO:0006907 |
pinocytosis(GO:0006907) |
| 0.0 |
0.1 |
GO:0001895 |
retina homeostasis(GO:0001895) |
| 0.0 |
0.1 |
GO:0001831 |
trophectodermal cellular morphogenesis(GO:0001831) |
| 0.0 |
0.4 |
GO:0016082 |
synaptic vesicle priming(GO:0016082) |
| 0.0 |
0.1 |
GO:0038032 |
termination of G-protein coupled receptor signaling pathway(GO:0038032) |
| 0.0 |
0.1 |
GO:0080182 |
histone H3-K4 trimethylation(GO:0080182) |
| 0.0 |
0.9 |
GO:0032526 |
response to retinoic acid(GO:0032526) |
| 0.0 |
0.4 |
GO:0046856 |
phospholipid dephosphorylation(GO:0046839) phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.0 |
0.3 |
GO:0046069 |
cGMP catabolic process(GO:0046069) |
| 0.0 |
0.1 |
GO:0033014 |
porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
| 0.0 |
0.4 |
GO:0043171 |
peptide catabolic process(GO:0043171) |
| 0.0 |
0.1 |
GO:1901164 |
negative regulation of trophoblast cell migration(GO:1901164) |
| 0.0 |
0.0 |
GO:0007250 |
activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.0 |
0.1 |
GO:0051639 |
actin filament network formation(GO:0051639) |
| 0.0 |
0.1 |
GO:0010918 |
positive regulation of mitochondrial membrane potential(GO:0010918) |
| 0.0 |
0.1 |
GO:0035751 |
regulation of lysosomal lumen pH(GO:0035751) |
| 0.0 |
0.1 |
GO:1904008 |
cellular response to salt(GO:1902075) response to monosodium glutamate(GO:1904008) cellular response to monosodium glutamate(GO:1904009) |
| 0.0 |
0.1 |
GO:0042517 |
positive regulation of tyrosine phosphorylation of Stat3 protein(GO:0042517) |
| 0.0 |
0.1 |
GO:0010574 |
regulation of vascular endothelial growth factor production(GO:0010574) |
| 0.0 |
0.1 |
GO:0051443 |
positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
| 0.0 |
0.8 |
GO:0006888 |
ER to Golgi vesicle-mediated transport(GO:0006888) |
| 0.0 |
0.0 |
GO:0016480 |
negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.0 |
0.0 |
GO:0030913 |
paranodal junction assembly(GO:0030913) |
| 0.0 |
0.1 |
GO:0043949 |
regulation of cAMP-mediated signaling(GO:0043949) |
| 0.0 |
0.1 |
GO:0072584 |
caveolin-mediated endocytosis(GO:0072584) |
| 0.0 |
0.0 |
GO:0071435 |
potassium ion export(GO:0071435) |
| 0.0 |
0.0 |
GO:0048227 |
plasma membrane to endosome transport(GO:0048227) |
| 0.0 |
0.4 |
GO:0001885 |
endothelial cell development(GO:0001885) |
| 0.0 |
0.1 |
GO:0001550 |
ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
| 0.0 |
0.0 |
GO:1904529 |
regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 0.0 |
0.1 |
GO:0031468 |
nuclear envelope reassembly(GO:0031468) |
| 0.0 |
0.1 |
GO:0043568 |
positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
| 0.0 |
0.1 |
GO:0002322 |
B cell proliferation involved in immune response(GO:0002322) |
| 0.0 |
0.1 |
GO:0060135 |
maternal process involved in female pregnancy(GO:0060135) |
| 0.0 |
0.3 |
GO:0030513 |
positive regulation of BMP signaling pathway(GO:0030513) |
| 0.0 |
0.3 |
GO:0031397 |
negative regulation of protein ubiquitination(GO:0031397) |
| 0.0 |
0.0 |
GO:0090285 |
negative regulation of protein glycosylation in Golgi(GO:0090285) |
| 0.0 |
0.1 |
GO:0051604 |
protein maturation(GO:0051604) |
| 0.0 |
0.0 |
GO:0098586 |
cellular response to virus(GO:0098586) |
| 0.0 |
0.0 |
GO:0046135 |
pyrimidine ribonucleoside catabolic process(GO:0046133) pyrimidine nucleoside catabolic process(GO:0046135) |
| 0.0 |
0.1 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
| 0.0 |
0.0 |
GO:0071839 |
apoptotic process in bone marrow(GO:0071839) |
| 0.0 |
0.1 |
GO:0035269 |
protein O-linked mannosylation(GO:0035269) |
| 0.0 |
0.7 |
GO:0043966 |
histone H3 acetylation(GO:0043966) |
| 0.0 |
0.1 |
GO:0010667 |
negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
| 0.0 |
0.6 |
GO:0000082 |
G1/S transition of mitotic cell cycle(GO:0000082) |
| 0.0 |
0.1 |
GO:0002507 |
tolerance induction(GO:0002507) |
| 0.0 |
0.1 |
GO:1901992 |
positive regulation of mitotic cell cycle phase transition(GO:1901992) |
| 0.0 |
0.3 |
GO:0045599 |
negative regulation of fat cell differentiation(GO:0045599) |
| 0.0 |
0.1 |
GO:0055010 |
ventricular cardiac muscle tissue morphogenesis(GO:0055010) |
| 0.0 |
0.0 |
GO:0048318 |
axial mesoderm development(GO:0048318) |
| 0.0 |
0.1 |
GO:0070389 |
chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.0 |
0.2 |
GO:0014829 |
vascular smooth muscle contraction(GO:0014829) |
| 0.0 |
0.0 |
GO:0072283 |
metanephric renal vesicle morphogenesis(GO:0072283) |
| 0.0 |
0.0 |
GO:0071380 |
cellular response to prostaglandin stimulus(GO:0071379) cellular response to prostaglandin E stimulus(GO:0071380) |
| 0.0 |
0.1 |
GO:0010991 |
negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.0 |
0.1 |
GO:0048702 |
embryonic neurocranium morphogenesis(GO:0048702) |
| 0.0 |
0.6 |
GO:0006635 |
fatty acid beta-oxidation(GO:0006635) |
| 0.0 |
0.0 |
GO:0046543 |
development of secondary female sexual characteristics(GO:0046543) |
| 0.0 |
0.0 |
GO:0031590 |
wybutosine metabolic process(GO:0031590) wybutosine biosynthetic process(GO:0031591) |
| 0.0 |
0.1 |
GO:0022417 |
protein maturation by protein folding(GO:0022417) |
| 0.0 |
0.2 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.0 |
0.0 |
GO:0070427 |
nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
| 0.0 |
0.1 |
GO:0003334 |
keratinocyte development(GO:0003334) |
| 0.0 |
0.0 |
GO:0001830 |
trophectodermal cell fate commitment(GO:0001830) |
| 0.0 |
0.1 |
GO:0046605 |
regulation of centrosome cycle(GO:0046605) |
| 0.0 |
0.1 |
GO:0006515 |
misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
| 0.0 |
0.1 |
GO:0043535 |
regulation of blood vessel endothelial cell migration(GO:0043535) |
| 0.0 |
0.2 |
GO:0006693 |
prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
| 0.0 |
0.3 |
GO:0007051 |
spindle organization(GO:0007051) |
| 0.0 |
0.0 |
GO:0045945 |
positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
| 0.0 |
0.2 |
GO:0070536 |
protein K63-linked deubiquitination(GO:0070536) |
| 0.0 |
0.1 |
GO:0000012 |
single strand break repair(GO:0000012) |
| 0.0 |
0.1 |
GO:0015840 |
urea transport(GO:0015840) urea transmembrane transport(GO:0071918) |
| 0.0 |
0.0 |
GO:1904666 |
regulation of ubiquitin protein ligase activity(GO:1904666) |
| 0.0 |
0.3 |
GO:0000271 |
polysaccharide biosynthetic process(GO:0000271) |
| 0.0 |
0.0 |
GO:0048254 |
snoRNA localization(GO:0048254) |
| 0.0 |
0.1 |
GO:0033599 |
regulation of mammary gland epithelial cell proliferation(GO:0033599) |
| 0.0 |
0.1 |
GO:0045540 |
regulation of cholesterol biosynthetic process(GO:0045540) |
| 0.0 |
0.1 |
GO:0070574 |
cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
| 0.0 |
0.1 |
GO:0019368 |
fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.0 |
0.3 |
GO:0030433 |
ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
| 0.0 |
0.1 |
GO:0098700 |
aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
| 0.0 |
0.5 |
GO:0010466 |
negative regulation of peptidase activity(GO:0010466) |
| 0.0 |
0.0 |
GO:0006573 |
valine metabolic process(GO:0006573) |
| 0.0 |
0.1 |
GO:0007213 |
G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
| 0.0 |
0.0 |
GO:0033169 |
histone H3-K9 demethylation(GO:0033169) |
| 0.0 |
0.0 |
GO:0021670 |
lateral ventricle development(GO:0021670) |
| 0.0 |
0.2 |
GO:0045669 |
positive regulation of osteoblast differentiation(GO:0045669) |
| 0.0 |
0.1 |
GO:0051013 |
microtubule severing(GO:0051013) |
| 0.0 |
0.1 |
GO:0046716 |
muscle cell cellular homeostasis(GO:0046716) |
| 0.0 |
0.3 |
GO:0015991 |
energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
| 0.0 |
0.1 |
GO:1900117 |
regulation of execution phase of apoptosis(GO:1900117) |
| 0.0 |
0.4 |
GO:0015804 |
neutral amino acid transport(GO:0015804) |
| 0.0 |
0.0 |
GO:0042138 |
meiotic DNA double-strand break formation(GO:0042138) |
| 0.0 |
0.2 |
GO:0048671 |
negative regulation of collateral sprouting(GO:0048671) |
| 0.0 |
0.1 |
GO:0042755 |
eating behavior(GO:0042755) |
| 0.0 |
0.0 |
GO:0023021 |
termination of signal transduction(GO:0023021) |
| 0.0 |
0.0 |
GO:0001867 |
complement activation, lectin pathway(GO:0001867) |
| 0.0 |
0.0 |
GO:0060830 |
ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
| 0.0 |
0.1 |
GO:0031122 |
cytoplasmic microtubule organization(GO:0031122) |
| 0.0 |
0.0 |
GO:1902902 |
negative regulation of autophagosome assembly(GO:1902902) |
| 0.0 |
0.0 |
GO:0030321 |
transepithelial chloride transport(GO:0030321) |
| 0.0 |
0.0 |
GO:0071873 |
response to norepinephrine(GO:0071873) |
| 0.0 |
0.0 |
GO:2000727 |
positive regulation of cardiocyte differentiation(GO:1905209) positive regulation of cardiac muscle cell differentiation(GO:2000727) |
| 0.0 |
0.1 |
GO:0035036 |
binding of sperm to zona pellucida(GO:0007339) sperm-egg recognition(GO:0035036) |
| 0.0 |
0.3 |
GO:0008045 |
motor neuron axon guidance(GO:0008045) |
| 0.0 |
0.1 |
GO:0009954 |
proximal/distal pattern formation(GO:0009954) |
| 0.0 |
0.1 |
GO:0060346 |
bone trabecula formation(GO:0060346) |
| 0.0 |
0.1 |
GO:0018206 |
peptidyl-methionine modification(GO:0018206) |
| 0.0 |
0.2 |
GO:0015914 |
phospholipid transport(GO:0015914) |
| 0.0 |
0.1 |
GO:0060670 |
branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 0.0 |
0.1 |
GO:0032288 |
myelin assembly(GO:0032288) |
| 0.0 |
0.1 |
GO:0060612 |
adipose tissue development(GO:0060612) |
| 0.0 |
0.0 |
GO:0051533 |
positive regulation of NFAT protein import into nucleus(GO:0051533) |
